1. Home
  2. QDEL vs PAHC Comparison

QDEL vs PAHC Comparison

Compare QDEL & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QDEL
  • PAHC
  • Stock Information
  • Founded
  • QDEL 1979
  • PAHC 1946
  • Country
  • QDEL United States
  • PAHC United States
  • Employees
  • QDEL N/A
  • PAHC N/A
  • Industry
  • QDEL Medical Specialities
  • PAHC Biotechnology: Pharmaceutical Preparations
  • Sector
  • QDEL Health Care
  • PAHC Health Care
  • Exchange
  • QDEL Nasdaq
  • PAHC Nasdaq
  • Market Cap
  • QDEL 1.4B
  • PAHC 1.5B
  • IPO Year
  • QDEL N/A
  • PAHC 2014
  • Fundamental
  • Price
  • QDEL $21.14
  • PAHC $44.48
  • Analyst Decision
  • QDEL Hold
  • PAHC Hold
  • Analyst Count
  • QDEL 6
  • PAHC 4
  • Target Price
  • QDEL $39.33
  • PAHC $31.25
  • AVG Volume (30 Days)
  • QDEL 1.7M
  • PAHC 324.6K
  • Earning Date
  • QDEL 11-05-2025
  • PAHC 11-05-2025
  • Dividend Yield
  • QDEL N/A
  • PAHC 1.06%
  • EPS Growth
  • QDEL N/A
  • PAHC 288.74
  • EPS
  • QDEL N/A
  • PAHC 1.67
  • Revenue
  • QDEL $2,714,400,000.00
  • PAHC $1,399,676,000.00
  • Revenue This Year
  • QDEL N/A
  • PAHC $14.80
  • Revenue Next Year
  • QDEL $2.65
  • PAHC $3.16
  • P/E Ratio
  • QDEL N/A
  • PAHC $27.13
  • Revenue Growth
  • QDEL N/A
  • PAHC 33.72
  • 52 Week Low
  • QDEL $19.50
  • PAHC $16.16
  • 52 Week High
  • QDEL $49.45
  • PAHC $46.42
  • Technical
  • Relative Strength Index (RSI)
  • QDEL 33.76
  • PAHC 62.55
  • Support Level
  • QDEL $20.42
  • PAHC $43.71
  • Resistance Level
  • QDEL $23.25
  • PAHC $44.00
  • Average True Range (ATR)
  • QDEL 1.70
  • PAHC 2.15
  • MACD
  • QDEL -0.48
  • PAHC 0.08
  • Stochastic Oscillator
  • QDEL 17.52
  • PAHC 73.40

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: